Buch, Englisch, 282 Seiten, Format (B × H): 127 mm x 191 mm, Gewicht: 644 g
Buch, Englisch, 282 Seiten, Format (B × H): 127 mm x 191 mm, Gewicht: 644 g
ISBN: 978-0-8493-0983-0
Verlag: Taylor & Francis
Zielgruppe
Physicians, Medical Researchers, PharmacologistsMarketing Class Code: 1I, 1L05, 1L09WEB CODES: LIF09, MED01C, MED01EShelving Guide: Medicine Contact Editor: Melissa Blockmon
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Infektionskrankheiten
- Naturwissenschaften Biowissenschaften Mikrobiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizin, Gesundheitswesen Epidemiologie, Medizinische Statistik
Weitere Infos & Material
Drug Resistance in Cancer, J.P. MarieMDR: Its Impact on Treatment of AIDS and TB, N.K. Ganguly and V.M. KatochCurrent Pandemics of Cholera and Strategy of Cholera Vaccines, J.-M. FournierEmerging Clones of Vibrio Cholerac and Multi-Drug Resistance, P. Garg, A. Basu, T. Ramaurthy, C. Sharma, S. Maiti, A. Ghosh, S.K. Bhattacharya, Y. Takeda, and G.B. NairEmergence of Plasmid-Mediated Antibiotic Resistance in Yersinia Pestis, A. Guiyoule, G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. CarnielProgress and Prospect of Chemotherapy Research in Leprosy, M.D.B. JiDiagnosis of Leprosy in India, U. SenguptaNew Drug Targets in Tuberculosis, J.L. Herrmann and P.H. LagrangeNewer DNA Fingerprinting Techniques for Tuberculosis-Relevance in Control, V.M. Katoch, D. Singh, D.S. Chauhan, V.D. Sharma, H.B. Singh, R. Das, and K. SrivastavaThe Molecular Basis of Isoniazid Resistance in Mycobacterium Tuberculosis, B. HeynMycobacterium tuberculosis: Studies on Gene Regulation, Pathogenesis and Development of Recombinant BCG Vaccines, A.K. Tyagi and S. Jain Progress for Deciphering Mycobacterium tuberculosis Pathogenicity, J.-M. Reyrat and B. GicquelMulti-Drug Resistant Tuberculosis, N. SelvakumarNew Targets for Malaria Drug Development, A.V. Pandey and V.S. ChauhanMolecular Aspects of Chloroquine and Antifols Resistance in Plasmodium falciparum, J. Le Bras and R. DurandImport of Host Enzymes into the Malarial Parasite can be a New Drug Target, Z.Q. Bonday and G. PadmanabanNew Drugs Against Malaria with Special Reference to Effectors of the Plasmodial Phospholipid Metabolism, H.J. Vial, V. Vidal-Sailhant, M.L. Ancelin, S. Herbute, D. Martin, F. Baunaure, and M. CalasStatus of Drug Resistance in Malaria in India, V.P. SharmaAntimalarial as Drug Resistance in Africa: Epidemiological Background of a Disaster, J.F. TrapeCan India Control the Spread of HIV/AIDS? T.J. JohnA Strategy to Control the Emergence of Antimicrobial Resistance, H. RichetNew Trends in Opportunistic Infections in HIV Patients, D. SereniOpportunistic Fungal and Mycobacterial Infections in Cancer Patients, R. KelkarPathogenicity of Enterovirulent Escherichia coli, A.L. ServinMulti-Drug Resistant Salmonella typhi: The Problem and Possible Solutions, M.V. JesudasonP53, BCL-2 and Drug Resistance in Cancer, A. TherwathMultiple Drug Resistance in Cancer, A.H. BhiseyDiagnostic Tools in Clinical for MDR, S. Chevillard, J. Ronert, and J.P. MarieMulti-Drug Resistance in Acute Leukaemias, M. Bhargava, S. Gurbuxani, J.-P. Marie, and A. TherwathMultiple Drug Resistance in Solid Tumors, P. VielhMulti-Drug Resistance: Therapeutic Regimen Against Bacteria and Virus Cells, A.V.R. Rao